From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
A systemic change from FFS to VBC would represent more than a payment model switch,…
From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
A systemic change from FFS to VBC would represent more than a payment model switch, but rather a holistic transition toward patient-centered healthcare that prioritizes outcomes over activity. The post From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology appeared first on MedCity News.
With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod…
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible. The post Eko Health’s AI for…
States Brace for Reversal of Obamacare Coverage Gains Under Trump’s Budget Bill
Shorter enrollment periods. More paperwork. Higher premiums. The sweeping tax and spending bill pushed by President Donald Trump includes provisions that would not only reshape people’s experience with the Affordable Care Act but, according to some policy analysts, also sharply undermine the gains in health insurance coverage associated with it. The moves affect consumers and…
KFF Health News’ ‘What the Health?’: Trump’s Bill Reaches the Finish Line
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care
It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn’t just about new medications or diagnostic tools; it’s about reimagining how and where we deploy our existing clinical expertise. The post What Administering My Father’s Home Infusions…
From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards. The post From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising appeared first on…
AI Is No Longer Optional in Senior Living – Here’s Why
Now is the time for senior living leaders to act and re-imagine what resident-centered, modern care can look like, today and in the future. The post AI Is No Longer Optional in Senior Living – Here’s Why appeared first on MedCity News.
The Healthcare Revolution at Your Home
The Healthcare Revolution at Your Home In today’s fast-paced world, finding time to visit a doctor can feel like a major challenge. Long work hours, family duties, traffic jams, and packed clinics make getting medical care stressful and inconvenient. For many people, especially seniors or those with mobility issues, even a short trip to the…
From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and Trust
Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step. The post From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and…
